We're excited to have Co-founder of Cambrian BioPharma, James Peyer, join us on an extra-special edition of TechCrunch Live on May 3 at 12 pm PDT.

On this episode of TechCrunch Live, we’ll get into how Peyer’s executive team has managed to attract top talent by giving them an oversized amount of equity compared to traditional pharmaceutical companies. Instead of developing pharmaceuticals inside Cambrian BioPharma, the company essentially spins out the solution with the top scientists sitting in the C-suite alongside seasoned Cambrian BioPharma executives who will help operate the new company.

Maryanna Saenko of Future Ventures is also speaking at this event. She sits on Cambrian BioPharma’s board of directors and invested in the company’s Series A, B, and C rounds. Together, the two are going to break down Cambrian BioPharma’s unique business model and explain why this process works so well.

The TCL virtual doors open at 11:30 am PDT for networking and the interview starts at 12:00 pm PDT. If you register, you can register for TCL Pitch Practice and ask James and Maryanna questions. We'll see you on May 3!

TechCrunch | ATOS | Customer Support | Unsubscribe

U.S. Region: Privacy Policy
Yahoo

701 First Avenue, Sunnyvale, CA 94089

Canada Region: Privacy Policy
Yahoo (Canada)

99 Spadina Ave, Suite 200, Toronto ON M5 J1A7, Canada

 European Region: Privacy Policy
Yahoo (EMEA)

5-7 Point Square, North Wall Quay, Dublin 1, Ireland

Australia: Privacy Policy

Yahoo Australia Pty Limited
Level 4 West
8 Central Avenue
Eveleigh, NSW 2015, Australia